Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy - A randomized, double-masked, cross-over study

K Rossing; KJ Schjoedt; UM Smidt; F Boomsma; HH Parving

doi:10.2337/diacare.28.9.2106

Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy - A randomized, double-masked, cross-over study

K Rossing, KJ Schjoedt, UM Smidt, F Boomsma, HH Parving

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

270 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2106-2112
Number of pages	7
Journal	Diabetes Care
Volume	28
Issue number	9
DOIs	https://doi.org/10.2337/diacare.28.9.2106
Publication status	Published - 2005

Research programs

EMC COEUR-01-43-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/diacare.28.9.2106

http://hdl.handle.net/1765/54874

Cite this

@article{d6411a949c32403297536068f337c606,

title = "Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy - A randomized, double-masked, cross-over study",

author = "K Rossing and KJ Schjoedt and UM Smidt and F Boomsma and HH Parving",

year = "2005",

doi = "10.2337/diacare.28.9.2106",

language = "Undefined/Unknown",

volume = "28",

pages = "2106--2112",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "9",

}

TY - JOUR

T1 - Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy - A randomized, double-masked, cross-over study

AU - Rossing, K

AU - Schjoedt, KJ

AU - Smidt, UM

AU - Boomsma, F

AU - Parving, HH

PY - 2005

Y1 - 2005

U2 - 10.2337/diacare.28.9.2106

DO - 10.2337/diacare.28.9.2106

M3 - Article

C2 - 16123474

SN - 0149-5992

VL - 28

SP - 2106

EP - 2112

JO - Diabetes Care

JF - Diabetes Care

IS - 9

ER -